-
Clinical Research Leaders Discuss Clinical Outcomes, Assessments And Technology At Boston Congress
12/1/2011
Attendees of PHT’s largest-ever annual PRO and ePRO Congress made it clear that PRO and ePRO are efficient, accurate, and economical methods to collect data within clinical trial research and post-market studies.
-
ePRO Innovator PHT Corporation Launches Live Chat 24/7 Global Customer Support
11/18/2011
PHT Corporation continues to define the standard for global ePRO customer support with the launch of the first live chat line in the ePRO industry.
-
VeriStrat® Results Correlate With Survival Outcomes In Kidney Cancer Patients
10/18/2011
Data presented at the 10th International Kidney Cancer Symposium being held in Chicago, IL show that the pretreatment blood-based test, VeriStrat, was able to stratify renal cell carcinoma (RCC) patients treated with a combination of two targeted therapies, sunitinib (Sutent®) and erlotinib (Tarceva®), by survival outcomes.
-
Symfo International And Isis Innovation Announce A Unique Turnkey Solution For Patient Reported Outcomes (PRO) Operations
7/8/2011
Isis Outcomes, a part of Isis Innovation Ltd, and Symfo are applying their respective areas of expertise to offer Sponsors and CROs a unique service that will help Drug Development/Study Managers to assess and choose the right PRO measure – validating and deploying PRO instruments, and ensuring that the study will meet Regulatory Authorities requirements.
